|
Barry Freedman, MD
|
|
NIH (1 U01 DK57298): Family investigation in nephropathy and diabetes (FIND) Genome Wide Association Study; Barry Freedman, PI.; Total Project Period: 5/1/09-4/30/11; Direct Costs: $65,000
|
|
NIH (RO1 DK070941): Genetic analysis of African American hypertensive end-stage renal disease;
Barry Freedman, PI;
Total Project Period: 5/1/06-4/30/10; Direct Costs: $286,630
|
|
NIH (RO1 DK071891): Subclinical CVD in African American type 2 diabetes; Barry Freedman, PI;
Total Project Period: 9/1/07-8/31/11; Direct Costs: $461,519
|
|
NIH (R01DK084149): Natural history of MYH-9-associated nephropathy; Barry Freedman, PI;
Michael Rocco, Co-I;
Total Project Period: 7/1/09-6/30/13; Direct Costs: $478,605
|
|
COLLABORATIVE
|
|
NIH-DK (RO1 DK53591--competitive renewal): Mapping genes for NIDDM nephropathy in African Americans; Donald Bowden, PI, Barry Freedman, Co-I; Total Project Period: 8/01/05-5/31/10;
Direct Costs: $345,311
|
|
NIH (DK56289):Identification of diabetes genes on human chromosome 20; Donald Bowden, PI;
Barry Freedman, Co-I
;Total Project Period: 9/15/05-7/31/10; Direct Costs: $232,304
|
|
NIH-NINDS (1R01 NS058700-01A1): Genetic epidemiology of cerebrovascular disease and
cognition in diabetes; Donald Bowden, PI, Barry Freedman, Co-I; Total Project Period: 4/1/08-3/31/13; Direct Costs: $444,389
|
|
NIH/NIAMS: Lupus nephritis and renal failure (LN/ESRD): A national consortium to explore the
genotypic basis for immune-mediated ESRD; Robert Kimberly, PI, Barry Freedman, Co-I; Total
Project Period: 9/30/09-9/29/11; Direct Costs: $140,132
|
|
NIH/NHLBI (HHSN268200900040C): Systolic blood pressure intervention trial (SPRINT); David
Reboussin, PI, Barry Freedman, Co-I; Total Project Period: 9/30/09-09/29/14; Direct Costs: $3,492,910
|
|
1R01KD090111-01: Mapping diabetic susceptibility by expression traits in African Americans;
Donald Bowden, PI, Barry Freedman, Co-I; Total Project Period: 12/1/10-11/30/15; Direct Costs:
$360,788
|
|
NIH (2 R01 DK066358): Genetics of African American type 2 diabetes; Donald Bowden, PI,
Barry Freedman, Co-I
; Total Project Period: 12/01/09-11/30/14; Direct Costs: $486,855
|
|
NIH (1 R01 HL92301-01A2): Whole genome association analysis of the Diabetes Heart Study;
Donald Bowden, PI, Barry Freedman, Co-I; Total Project Period: 12/01/09-11/30/14; Direct Costs:
$499,362
|
|
NIH (DK87914): Genetic determinants of adiposity in African Americans; Maggie Ng, PI, Barry
Freedman, Co-I;
Total Project Period: 4/1/10-3/31/15; Direct Costs: $499,180
|
|
Pirouz Daeihagh, MD
|
|
HemaMetrics: A randomized prospective controlled trial of ultrafiltration modeling using a blood volume
Monitoring device (Crit-Line) in hypervolemic intensive care unit patients with acute kidney injury
Requiring renal replacement therapy using CRRT. Pirouz Daeihagh, PI, Michael Rocco, Co-I. Total
Project Period: 10/1/09-9/30/11; Direct Costs: $30,000
|
|
Shahriar Moossavi, MD
|
|
PEP
-08-274-01-PC2: Paricalcitol for Palliation in Advanced Prostate Cancer: A Phase II Trial;
Gary Schwartz, PI; Shahriar Moossavi, Co-I; Total Project Period: 8/31/08-8/31/10
|
|
Amber Reeves-Daniel, MD
|
|
Southern Easter Kidney Council Network. Registry of kidney donors outcomes of living kidney donation. Amber Reeves-Daniel, PI; Total Project Period: 1/1/09-12/31/10; Direct Costs: $15,000
|
|
Michael Rocco
, M.D
|
|
NIH-NIDDK (U01 DK066579): Frequent hemodialysis clinical trials: daily in-center clinical cite (Contracting Center, Renal Research Institute); Michael Rocco, PI at WFSM; Total Project Period: 9/30/03-9/31/11; Direct Costs: $97,554
|
|
NIH-NIDDK (U01 DK66480): Frequent hemodialysis clinical trials: nocturnal hemodialysis clinical coordinating center; Michael Rocco, PI; Total Project Period: 9/1/03-1/31/11; Direct Costs: $267,397
|
|
NIH (1 Ro1 DK074715-01A1): Cognitive function in dialysis patients: ancillary study to the FHN
trial (Contracting Center, University of Iowa); Michael Rocco, PI at WFSM; Total Project Period: 1/1/08-7/31/11; Direct Costs: $16,000
|
|
HHSN268200900048C:
NIH/NHLBI;Systolic Blood Pressure Intervention Trial (SPRINT); David Goff, PI, Michael Rocco, Co-I; Amret Hawfield, Co-I. Total Project Period: 8/31/09-8/30/14; Direct Costs: $1,497,947
|
|
WFSM Intramural Grant: Blood oxygenation level-dependent (BOLD) MRI for non-invasive determination of real blood flow and oxygenation. Michael Rocco, PI; Vardaman Buckalew, Co-I: Total Project Period: 10/1/09-9/30/10. Direct Costs: $41,314
|
|
Tushar Vachharajani, M.D.
|
|
Tyco Healthcare Group LP. A randomized,open-label comparison of the performance and longevity of a split-tip versus a symmetric tip hemodialysis catheter;
Tushar Vachharajani, PI; Shahriar Moossavi, MD, Co-I
. Total Project Period: 11/1/07-3/31/2011. Direct Costs: $864,230.16
|